JNJ
Price
$170.86
Change
+$0.27 (+0.16%)
Updated
Aug 7, 02:38 PM (EDT)
Capitalization
380.22B
75 days until earnings call
RHHVF
Price
$305.87
Change
-$9.11 (-2.89%)
Updated
Aug 6 closing price
Capitalization
250.69B
77 days until earnings call
Interact to see
Advertisement

JNJ vs RHHVF

Header iconJNJ vs RHHVF Comparison
Open Charts JNJ vs RHHVFBanner chart's image
Johnson & Johnson
Price$170.86
Change+$0.27 (+0.16%)
Volume$2.68K
Capitalization380.22B
Roche Holding
Price$305.87
Change-$9.11 (-2.89%)
Volume$928
Capitalization250.69B
JNJ vs RHHVF Comparison Chart in %
Loading...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JNJ vs. RHHVF commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNJ is a Hold and RHHVF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (JNJ: $170.59 vs. RHHVF: $305.87)
Brand notoriety: JNJ: Notable vs. RHHVF: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: JNJ: 107% vs. RHHVF: 19%
Market capitalization -- JNJ: $380.22B vs. RHHVF: $250.69B
JNJ [@Pharmaceuticals: Major] is valued at $380.22B. RHHVF’s [@Pharmaceuticals: Major] market capitalization is $250.69B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JNJ’s FA Score shows that 4 FA rating(s) are green whileRHHVF’s FA Score has 1 green FA rating(s).

  • JNJ’s FA Score: 4 green, 1 red.
  • RHHVF’s FA Score: 1 green, 4 red.
According to our system of comparison, JNJ is a better buy in the long-term than RHHVF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JNJ’s TA Score shows that 7 TA indicator(s) are bullish while RHHVF’s TA Score has 5 bullish TA indicator(s).

  • JNJ’s TA Score: 7 bullish, 4 bearish.
  • RHHVF’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, JNJ is a better buy in the short-term than RHHVF.

Price Growth

JNJ (@Pharmaceuticals: Major) experienced а +1.99% price change this week, while RHHVF (@Pharmaceuticals: Major) price change was -4.96% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.58%. For the same industry, the average monthly price growth was +7.69%, and the average quarterly price growth was +14.72%.

Reported Earning Dates

JNJ is expected to report earnings on Oct 21, 2025.

RHHVF is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.58% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JNJ($380B) has a higher market cap than RHHVF($251B). JNJ has higher P/E ratio than RHHVF: JNJ (30.34) vs RHHVF (19.34). JNJ YTD gains are higher at: 19.921 vs. RHHVF (9.239). JNJ has higher annual earnings (EBITDA): 23.3B vs. RHHVF (19.1B). JNJ has more cash in the bank: 22.9B vs. RHHVF (7.51B). RHHVF has less debt than JNJ: RHHVF (25.4B) vs JNJ (29.3B). JNJ has higher revenues than RHHVF: JNJ (85.2B) vs RHHVF (60B).
JNJRHHVFJNJ / RHHVF
Capitalization380B251B151%
EBITDA23.3B19.1B122%
Gain YTD19.9219.239216%
P/E Ratio30.3419.34157%
Revenue85.2B60B142%
Total Cash22.9B7.51B305%
Total Debt29.3B25.4B115%
FUNDAMENTALS RATINGS
JNJ vs RHHVF: Fundamental Ratings
JNJ
RHHVF
OUTLOOK RATING
1..100
7451
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
15
Undervalued
PROFIT vs RISK RATING
1..100
29100
SMR RATING
1..100
3298
PRICE GROWTH RATING
1..100
2573
P/E GROWTH RATING
1..100
8151
SEASONALITY SCORE
1..100
6550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RHHVF's Valuation (15) in the null industry is in the same range as JNJ (21) in the Pharmaceuticals Major industry. This means that RHHVF’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's Profit vs Risk Rating (29) in the Pharmaceuticals Major industry is significantly better than the same rating for RHHVF (100) in the null industry. This means that JNJ’s stock grew significantly faster than RHHVF’s over the last 12 months.

JNJ's SMR Rating (32) in the Pharmaceuticals Major industry is significantly better than the same rating for RHHVF (98) in the null industry. This means that JNJ’s stock grew significantly faster than RHHVF’s over the last 12 months.

JNJ's Price Growth Rating (25) in the Pharmaceuticals Major industry is somewhat better than the same rating for RHHVF (73) in the null industry. This means that JNJ’s stock grew somewhat faster than RHHVF’s over the last 12 months.

RHHVF's P/E Growth Rating (51) in the null industry is in the same range as JNJ (81) in the Pharmaceuticals Major industry. This means that RHHVF’s stock grew similarly to JNJ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
JNJRHHVF
RSI
ODDS (%)
Bearish Trend 1 day ago
43%
Bullish Trend 1 day ago
70%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
44%
Bullish Trend 1 day ago
58%
Momentum
ODDS (%)
Bullish Trend 7 days ago
49%
Bearish Trend 1 day ago
58%
MACD
ODDS (%)
Bullish Trend 7 days ago
49%
Bearish Trend 1 day ago
53%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
40%
Bearish Trend 1 day ago
58%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
40%
Bearish Trend 1 day ago
64%
Advances
ODDS (%)
Bullish Trend 4 days ago
41%
Bullish Trend 15 days ago
53%
Declines
ODDS (%)
Bearish Trend 1 day ago
43%
Bearish Trend 1 day ago
56%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
48%
Bullish Trend 1 day ago
68%
Aroon
ODDS (%)
Bullish Trend 1 day ago
42%
Bullish Trend 1 day ago
50%
View a ticker or compare two or three
Interact to see
Advertisement
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IWP141.050.47
+0.33%
iShares Russell Mid-Cap Growth ETF
MYI10.530.03
+0.29%
Blackrock Muniyield Quality Fund III
BLUBF5.58N/A
N/A
Blue Ribbon Income Fund
SMLV124.14-0.04
-0.03%
SPDR® SSGA US Small Cap Low Volatil ETF
PXI42.31-0.23
-0.53%
Invesco Dorsey Wright Energy MomentumETF

RHHVF and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHVF has been loosely correlated with RHHBY. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHVF jumps, then RHHBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHVF
1D Price
Change %
RHHVF100%
-2.89%
RHHBY - RHHVF
65%
Loosely correlated
-2.69%
JNJ - RHHVF
31%
Poorly correlated
-0.09%
NVS - RHHVF
27%
Poorly correlated
-3.59%
AZN - RHHVF
26%
Poorly correlated
-1.18%
RHHBF - RHHVF
25%
Poorly correlated
-3.88%
More